MIMEDX GROUP INC (MDXG) Stock Price & Overview
NASDAQ:MDXG • US6024961012
Current stock price
The current stock price of MDXG is 4.12 USD. Today MDXG is down by -1.2%. In the past month the price decreased by -20.31%. In the past year, price decreased by -48.11%.
MDXG Key Statistics
- Market Cap
- 612.108M
- P/E
- 10.05
- Fwd P/E
- 35.64
- EPS (TTM)
- 0.41
- Dividend Yield
- N/A
MDXG Stock Performance
MDXG Stock Chart
MDXG Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to MDXG. When comparing the yearly performance of all stocks, MDXG is a bad performer in the overall market: 93.28% of all stocks are doing better.
MDXG Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to MDXG. MDXG scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
MDXG Earnings
On February 25, 2026 MDXG reported an EPS of 0.1 and a revenue of 118.09M. The company beat EPS expectations (16.71% surprise) and beat revenue expectations (8.43% surprise).
MDXG Forecast & Estimates
12 analysts have analysed MDXG and the average price target is 9.86 USD. This implies a price increase of 139.32% is expected in the next year compared to the current price of 4.12.
For the next year, analysts expect an EPS growth of -71.81% and a revenue growth -14.71% for MDXG
MDXG Groups
Sector & Classification
MDXG Financial Highlights
Over the last trailing twelve months MDXG reported a non-GAAP Earnings per Share(EPS) of 0.41. The EPS increased by 41.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.6% | ||
| ROA | 14.18% | ||
| ROE | 18.94% | ||
| Debt/Equity | 0.06 |
MDXG Ownership
MDXG Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.82 | 364.65B | ||
| AMGN | AMGEN INC | 15.24 | 188.631B | ||
| GILD | GILEAD SCIENCES INC | 15.52 | 175.177B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.42 | 116.358B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.68 | 77.963B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 41.84 | 41.258B | ||
| INSM | INSMED INC | N/A | 31.039B | ||
| NTRA | NATERA INC | N/A | 28.733B | ||
| BIIB | BIOGEN INC | 11.29 | 26.917B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.55 | 23.098B | ||
| MRNA | MODERNA INC | N/A | 20.683B | ||
| EXAS | EXACT SCIENCES CORP | 345.14 | 19.837B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.676B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About MDXG
Company Profile
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. The company is headquartered in Marietta, Georgia and currently employs 808 full-time employees. The company went IPO on 2007-08-20. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The company also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
Company Info
IPO: 2007-08-20
MIMEDX GROUP INC
1775 W Oak Commons Court, Ne
Marietta GEORGIA 30062 US
CEO: Timothy R. Wright
Employees: 837
Phone: 17706519100
MIMEDX GROUP INC / MDXG FAQ
Can you describe the business of MIMEDX GROUP INC?
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. The company is headquartered in Marietta, Georgia and currently employs 808 full-time employees. The company went IPO on 2007-08-20. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The company also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
Can you provide the latest stock price for MIMEDX GROUP INC?
The current stock price of MDXG is 4.12 USD. The price decreased by -1.2% in the last trading session.
Does MDXG stock pay dividends?
MDXG does not pay a dividend.
What is the ChartMill technical and fundamental rating of MDXG stock?
MDXG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Is MIMEDX GROUP INC (MDXG) expected to grow?
The Revenue of MIMEDX GROUP INC (MDXG) is expected to decline by -14.71% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for MIMEDX GROUP INC?
MIMEDX GROUP INC (MDXG) currently has 837 employees.